| Guideline | Drug Name |
|---|---|
| Contraceptives for Non-Contraceptive Use | Contraceptives |
| Copiktra (duvelisib) | Copiktra (duvelisib) |
| Copper Chelating Agents - PA, NF | Cuprimine (penicillamine), Cuvrior (trientine tetrahydrochloride), Syprine (trientine) |
| Cosela (trilaciclib) - PA, NF | Cosela (trilaciclib) |
| Cosentyx (secukinumab) - PA, NF | Cosentyx IV (secukinumab), Cosentyx SC (secukinumab) |
| Cotellic (cobimetinib) | Cotellic (cobimetinib) |
| Coverage of Drugs for Off-Label or Non-FDA Approved Indications | |
| Crenessity (crinecerfont) | Crenessity (crinecerfont) |
| Crinone Gel 8% Quantity Limit | Crinone Gel 8% |
| Crysvita (burosumab-twza) | Crysvita (burosumab-twza) |
| Daliresp (roflumilast) | Daliresp (roflumilast) |
| Danziten (nilotinib) | Danziten (nilotinib) |
| Daraprim (pyrimethamine) | Daraprim (pyrimethamine) |
| Darzalex (daratumumab), Darzalex Faspro (daratumumab and hyaluronidase-fihj) - PA, NF | Darzalex (daratumumab), Darzalex Faspro (daratumumab and hyaluronidase-fihj) |
| Daurismo (glasdegib) | Daurismo (glasdegib) |
| DAW Override | DAW override, Dispense, written |
| Daxxify (botulinum toxin type a injection) | Daxxify (botulinum toxin type a injection) |
| Daybue (trofinetide) - PA, NF | Daybue (trofinetide) |
| Deferasirox products | Exjade (deferasirox), deferasirox tablet, Jadenu (deferasirox), Jadenu Sprinkle (deferasirox) |
| Deflazacort products - PA, NF | Brand Emflaza (deflazacort), generic deflazacort, Jaythari (deflazacort) |
HEALTHY LIVING